Menopause Care & Workplace Support Services Market

What is the menopause care and workplace support services market forecast to be worth by 2036?

USD 3.0 billion in services in 2026 to USD 40.0 billion by 2036, at 29.6% CAGR.

• The menopause care and workplace support services market crossed a valuation of USD 2.3 billion in services in 2025.
• Demand is expected to increase from USD 3.0 billion in services in 2026 to USD 40.0 billion by 2036.
• The market is forecast to record 29.6% CAGR during 2026 to 2036 as specialized clinics and employer benefits programs scale.

What are the defining numbers behind menopause care and workplace support services growth?

USD 37.0 billion absolute opportunity by 2036, led by the United Kingdom and the United States.

• Demand Drivers in the Market
  • Women need specialist care because menopause symptoms can affect sleep and working life.
  • Employers need benefits that support retention of experienced midlife employees.
  • Health plans need structured care pathways for an undertreated population.
  • Digital clinics need scalable care models across perimenopause and postmenopause.
• Key Segments Analyzed
  • By Service Type: Specialized menopause telehealth clinics are expected to hold 36.0% share in 2026 as virtual access solves specialist-care gaps.
  • By Care Stage: Perimenopause care leads because symptoms often begin before final menstrual period. The share is projected at 39.0% in 2026.
  • By Customer Type: Employers and health plans are likely to account for 40.0% share in 2026 because benefits programs are becoming a formal access channel.
  • By Delivery Model: Virtual clinic and app-based care leads as women need private access to specialist support. The model is projected to hold 42.0% share in 2026.
  • By End Use: Symptom management and clinical care is expected to hold 38.0% share in 2026 as symptom relief drives first service adoption.
  • By Geography: The United Kingdom is projected to record 33.8% CAGR through 2036 as workplace menopause guidance and employer action plans expand.
• Analyst Opinion at Fact.MR
  • Shambhu Nath Jha, Senior Analyst at Fact.MR, states, “Menopause care is becoming a structured service market across workplaces and telehealth platforms. Employers are looking for ways to support midlife women and retain experienced talent. Providers that combine clinical care and workplace training will gain stronger access to women’s health benefits budgets.”
• Strategic Implications
  • Employers should add menopause benefits to reduce attrition among experienced workers.
  • Telehealth clinics need specialist provider networks that can support symptom management at scale.
  • Health plans should treat menopause care as midlife preventive care, not a short-term consultation.
  • Workplace platforms need policy training and confidential care navigation in one service model.

Specialized menopause clinics and employer benefits programs covering perimenopause-to-postmenopause care for the 1B+ women in menopause globally by 2030. WHO states that the global population of postmenopausal women is growing, and women aged 50 and over accounted for 26% of all women and girls globally in 2021. [1] This creates a large care base for midlife women’s health services.

The United Kingdom is projected to record 33.8% CAGR from 2026 to 2036 as workplace menopause guidance and employer action plans expand. The United States is likely to post 33.2% CAGR as Midi and other digital clinics scale through employers and health plans. Canada is expected to register 31.6% CAGR as employer benefits and midlife women’s health access improve. Australia is forecast to advance at 30.8% CAGR as telehealth care and workplace policies gain adoption. Germany is set to record 29.7% CAGR by 2036 as clinical care demand and employer support programs expand.

How does the menopause care and workplace support services market break down by segment?

Specialized Menopause Telehealth Clinics lead at 36.0%; Perimenopause Care leads at 39.0%.

Which service type dominates?

Specialized Menopause Telehealth Clinics hold 36.0% share in 2026.

Specialized menopause telehealth clinics are expected to hold 36.0% share in 2026 because many women lack easy access to menopause-trained clinicians. Carrot launched a virtual menopause and midlife clinic in 2025 that gives members access to vetted menopause specialists, menopause-related medications, mental and emotional support, nutritionists and dietitians [2]. Virtual clinics can connect women with menopause-focused clinicians and coaches without long specialist wait times.

Which care stage dominates?

Perimenopause care leads because symptoms often begin before final menstrual period.

Perimenopause care leads because many women first seek help during irregular cycles and mood changes. The care stage is projected to capture 39.0% share in 2026 as awareness improves among women aged 40 to 55. EHRC guidance states that menopause usually happens between ages 45 and 55, and perimenopause is the stage with symptoms before periods stop. [3] Early care helps women manage symptoms before work and daily life are heavily disrupted.

Which customer type dominates?

Employers and Health Plans hold 40.0% share in 2026.

Employers and health plans are likely to account for 40.0% share in 2026 because workplace benefits are becoming a major access channel. Maven stated that its menopause program covered 3.5 million lives across more than 350 employers in 2024. [4] Employers need programs that support experienced employees and reduce avoidable exits. Health plans can also use menopause benefits to improve midlife women’s health access.

Which delivery model dominates?

Virtual Clinic and App-Based Care leads because women need private and flexible access.

Virtual clinic and app-based care leads because menopause symptoms often require repeated support rather than a single visit. The model is projected to hold 42.0% share in 2026 as platforms combine clinicians and follow-up. Digital care fits workplace benefits because employees can access support privately.

Which end use dominates?

Symptom Management and Clinical Care holds 38.0% share in 2026.

Symptom management and clinical care leads because relief from disruptive symptoms is the first reason women seek support. The end use is expected to hold 38.0% share in 2026 as women look for help with vasomotor symptoms and genitourinary symptoms. Care services combine clinical review with education and lifestyle support

What is accelerating menopause care and workplace support demand, and what is holding it back?

Workplace policy momentum and undertreated symptoms drive demand; stigma and care gaps restrain adoption.

Workplace policy momentum is the main driver. The Equality and Human Rights Commission’s 2024 menopause workplace guidance says employers should consider workplace adjustments and understand their legal duties to support workers experiencing menopausal symptoms [5]. This supports demand for menopause care and workplace support services as employers formalize policies and employee assistance routes.

The main restraint is stigma. Many women may not ask for support even if symptoms affect work and health. Providers must offer confidential access and clear education before adoption can scale.

Where do the biggest menopause care and workplace support opportunities sit?

Telehealth clinics and manager training.

• Telehealth Clinics: Providers can deliver menopause specialist access across regions with limited in-person care.
• Employer Benefits: Companies can support retention through confidential care and symptom management services.
• Manager Training: Workplace platforms can help managers support employees without stigma or inappropriate disclosure.

Which countries are scaling menopause care and workplace support services fastest?

United Kingdom 33.8%, United States 33.2%, Canada 31.6%, Australia 30.8%, Germany 29.7%.

Based on regional analysis, the menopause care and workplace support services market is segmented into Western Europe, North America, Asia Pacific, Latin America, and Middle East and Africa.

What is powering the United Kingdom lead?

The United Kingdom is projected to record 33.8% CAGR through 2036 as workplace menopause guidance and employer action plans expand. Peppy gives the United Kingdom market an employer-benefit service model focused on menopause support. Demand will focus on workplace education and confidential care navigation. Employers will use these services to support retention and reduce avoidable absence among experienced workers.

How is the United States scaling menopause care demand?

The United States is likely to post 33.2% CAGR through 2036 as Midi and other digital clinics scale through employers and health plans. U.S. demand will favor insured telehealth care and personalized symptom management. Growth will be strongest among large employers and health plans seeking women’s health benefits beyond fertility and maternity.

What underpins Canada’s growth?

Canada is expected to register 31.6% CAGR through 2036 as employer benefits and midlife women’s health access improve. Canadian employers are adding more gender-specific health support as workforce retention becomes a bigger priority. Women in midlife need symptom care and credible information. Employer benefit consultants can help companies introduce menopause support without creating stigma. Demand will favor virtual-care models that work across provinces. Growth will be strongest among large employers and professional services firms with midlife workforce concentration.

How is Australia scaling menopause workplace support?

Australia is forecast to advance at 30.8% CAGR through 2036 as telehealth care and workplace policies gain adoption. Employers are becoming more aware that menopause symptoms can affect productivity and participation. Telehealth gives women private access to clinicians and coaches, including outside major cities. Workplace programs can support managers and symptom education. Demand will favor integrated services that combine care navigation and employer guidance.

Why is Germany an important menopause care market?

Germany is set to record 29.7% CAGR through 2036 as clinical care demand and employer support programs expand. Women in midlife need evidence-based symptom support and preventive health guidance. German employers will increasingly treat menopause as a workforce health and retention issue. Health plans can support menopause care through structured consultations and digital pathways.

Who leads the menopause care and workplace support services landscape?

Midi Health and Peppy lead through menopause telehealth and employer benefit programs.

Menopause care and workplace support services are used by women and health plans that need structured support through midlife health changes. Midi Health provides virtual care for menopause and perimenopause and offers an employer access model. Maven Clinic provides Menopause and Midlife Health support through employer and health plan channels. Peppy provides menopause care as an employee benefit.

Elektra Health supports workplace menopause education and care access. Gennev, through Unified Women’s Healthcare, offers virtual menopause care supported by clinicians and registered dietitian nutritionists.

Competition through 2036 will depend on clinical access and measurable workforce outcomes. Providers that combine medical care with coaching and workplace training will be better placed. Telehealth clinics can win direct-to-consumer and insured care. Employer-benefit platforms can win HR budgets. Integrated women’s health providers can support menopause care alongside broader midlife health services.

Which companies are the key players?

Midi Health, Maven Clinic, Peppy, Elektra Health and Gennev.

• Midi Health
• Maven Clinic
• Peppy
• Elektra Health
• Gennev (Unified)

Bibliography

• [1] World Health Organization. (2024, October 16). Menopause. World Health Organization.
• [2] Carrot. (2025, February 4). Carrot launches virtual menopause and midlife clinic. Carrot.
• [3] Equality and Human Rights Commission. (2024, February 22). Menopause in the workplace: Guidance for employers. Equality and Human Rights Commission.
• [4] Maven Clinic. (2024, January 18). Maven Clinic and BSI partner to offer industry-leading menopause support to BSI employees worldwide. Maven Clinic.
• [5] Equality and Human Rights Commission. (2024, February 22). Menopause in the workplace: Guidance for employers. Equality and Human Rights Commission.

This Report Addresses

• Strategic intelligence on menopause care and workplace support services across service type, care stage and customer type.
• Segment analysis covering Specialized Menopause Telehealth Clinics, Perimenopause Care, Employers and Health Plans, Virtual Clinic and App-Based Care and Symptom Management.
• Regional outlook covering the United Kingdom, United States, Canada, Australia and Germany.
• Competitive analysis of Midi Health, Maven Clinic, Peppy, Elektra Health and Gennev.
• Service assessment covering menopause telehealth, employer benefits, symptom care and workplace policy support.
• Care-stage assessment covering perimenopause, menopause symptom care, postmenopause health and midlife preventive care.
• Primary interviews, provider checks, official source review and employer benefits validation support the forecast.

What does the menopause care and workplace support services market cover?

Specialized clinical care and employer benefit programs.

The menopause care and workplace support services market covers clinical and workplace services for women in perimenopause and postmenopause. It includes symptom management and manager training. The market differs from menopause drug markets because the focus is service delivery and employer benefits.

What is included in the scope?

Telehealth care and workplace policy services.

The scope includes specialized menopause consultations and ongoing symptom support. It covers employer-funded menopause benefits and policy guidance. It includes lifestyle coaching and mental health navigation tied to menopause care. It also includes midlife preventive care delivered through menopause-focused service platforms.

What is excluded from the scope?

Drug manufacturing and general wellness programs without menopause-specific support.

The scope excludes hormone therapy drug manufacturing and pharmaceutical sales. It excludes generic telehealth services with no menopause care component. It excludes broad wellness apps unless menopause support is part of the service. It also excludes workplace diversity programs that do not provide menopause policy or care support.

How was the analysis built?

100+ sources, 45+ company portfolios, 25+ countries, 20+ interviews.

• Primary Research: Primary research includes interviews with employer benefits teams and menopause care providers. It includes input from telehealth clinics and workplace wellbeing consultants.
• Desk Research: Desk research reviews WHO menopause evidence and workplace guidance. It covers official provider pages and menopause care service disclosures.
• Market-Sizing and Forecasting: Forecasting uses women aged 45 to 60 in covered regions and clinic service intensity. Telehealth penetration and payer coverage support the market assessment.
• Data Validation and Update Cycle: Forecasts are validated through provider checks and employer benefits review. Workplace policy updates and telehealth care expansion help confirm market direction.